![]() |
Volumn 20, Issue 11, 1999, Pages 465-469
|
Cyclooxygenase 2 inhibitors: Discovery, selectivity and the future
|
Author keywords
[No Author keywords available]
|
Indexed keywords
5 BROMO 2 (4 FLUOROPHENYL) 3 (4 METHYLSULFONYLPHENYL)THIOPHENE;
ACETYLSALICYLIC ACID;
CELECOXIB;
INDOMETACIN;
N (2 CYCLOHEXYLOXY 4 NITROPHENYL)METHANESULFONAMIDE;
O (ACETOXYPHENYL)HEPT 2 YNYL SULFIDE;
PROSTAGLANDIN SYNTHASE INHIBITOR;
ROFECOXIB;
UNCLASSIFIED DRUG;
ANALGESIC ACTIVITY;
ANTIINFLAMMATORY ACTIVITY;
DRUG CONFORMATION;
ENZYME INHIBITION;
HUMAN;
NONHUMAN;
PRIORITY JOURNAL;
PROSTAGLANDIN SYNTHESIS INHIBITION;
REVIEW;
STRUCTURE ACTIVITY RELATION;
ANIMALS;
CYCLOOXYGENASE 2;
CYCLOOXYGENASE 2 INHIBITORS;
CYCLOOXYGENASE INHIBITORS;
HUMANS;
ISOENZYMES;
MEMBRANE PROTEINS;
PROSTAGLANDIN-ENDOPEROXIDE SYNTHASES;
PROTEIN CONFORMATION;
|
EID: 0032702213
PISSN: 01656147
EISSN: None
Source Type: Journal
DOI: 10.1016/S0165-6147(99)01385-1 Document Type: Review |
Times cited : (223)
|
References (52)
|